[1]
H. P. . Cheng, “USE OF SUBCUTANEOUS LONG-ACTING SOMATOSTATIN ANALOGUE OCTREOTIDE LAR IN A CHILD WITH CONGENITAL HYPERINSULINISM”, J ASEAN Fed Endocr Soc, vol. 36, p. 69, Jul. 2021.